Why Present at TCT 2021?

Step into the Main Arena to share your research with an international audience of colleagues and leading experts in interventional cardiovascular medicine! Grow your professional presence among the more than 11,000 attendees from more than 100 countries — and make a global impact on the field!


  • Attract international recognition.
  • Elevate your professional social media presence.
  • Improve your competitiveness for scholarships and grants.
  • Gain an abstract publication in The Journal of the American Cardiology (JACC).

Questions? Email us at

Submission opens Tuesday, March 30, 2021
Submit by Tuesday, July 27, 2021 at 2:00 PM EDT (UTC −4)

Submit your abstracts of original research for the opportunity to present to thousands of your colleagues worldwide. Research can be in the form of clinical studies, basic science investigations, or preclinical studies and must be relevant to interventional cardiology, endovascular medicine, or structural heart disease. Your abstracts must convey original research but can include portions of previous abstracts and/or manuscripts presented elsewhere. Abstracts that are selected will be published in JACC. Note: Submit single-patient case reports to Challenging Cases, regardless of the novelty of the case.

Guidelines: Character limit is 2,200, including spaces (approximately 300-350 words).

Submit Now

Submission opens Tuesday, April 6, 2021
Submit by Tuesday, June 29, 2021 at 2:00 PM EDT (UTC −4)

Physicians and fellows from around the world, submit your most challenging coronary, endovascular, and structural heart disease cases. The best cases will be chosen by TCT 2021 course directors for presentation.

Guidelines: Character limit is 2,450 total for case summary, history, diagnostic tests, procedure, conclusion, comments. PowerPoint slide presentation highlighting your case is optional. Images: 10 MB. Video formats accepted: 30 MB mpeg, wmv, avi, mov, mpg, mp4

Submit Now

Submission opens Tuesday, April 20, 2021
Submit by Thursday, August 19, 2021 at 2:00 PM EDT (UTC −4)

Late-Breaking Clinical Trials and Science are typically:

  • First-time presentations of first-in-human experiences with novel devices or drugs
  • Primary or important secondary endpoint results of prospective randomized clinical trials
  • Large-scale, impactful single-/multicenter registries

Accepted submissions will be presented in the Main Arena at TCT 2021. In addition to being presented in the Main Arena, selected Late-Breaking Clinical Trials and Science are also selected for presentation during press conferences scheduled on the same day. Presentations of accepted late-breaking trials and science are strictly embargoed until time of presentation.

Please note that the following rarely qualify as late-breaking clinical trial submissions and instead, should be submitted as abstracts or to call for innovation: preclinical studies, early first-in-human device studies, and meta-analyses.

Submit Now

Guidelines: Total character limit is 3,250, including spaces (primary endpoints: 550 character limit; secondary endpoints: 550 character limit; funding sources: 500 character limit). Upload .png or .jpg files only.

Submission opens Tuesday, April 6, 2021
Submit by Tuesday, June 29, 2021 at 2:00 PM EDT (UTC −4)

This award recognizes clinical and academic excellence in interventional cardiovascular medicine and aims to stimulate the continued commitment and dedication to both outstanding patient care and ongoing academic inquiry by young investigators.

The three finalists will become faculty at TCT 2021. The winner will be announced at the conference and will receive the award along with a $10,000 scholarship in the Main Arena.

We encourage both international and US-based applicants. Candidates for this award must be:

  • Younger than 41 years old at the start of TCT 2021 (November 4, 2021)
  • Specializing in interventional cardiovascular medicine (interventional cardiology, endovascular medicine, structural heart disease, pathology, etc.)

Guidelines: Required documents: CV, personal statement, clinical accomplishments, letters of recommendation, and supplemental information.

Submit Now

Submission open Tuesday, March 30, 2021
Submit by Tuesday, July 27, 2021 at 2:00 PM EDT (UTC −4)

TCT Innovation Sessions

Submit your novel technologies relevant to the monitoring, diagnosis, and treatment of coronary, endovascular, or structural heart disease. Selected emerging technologies will be presented at TCT 2021.

TCT Shark Tank Innovation Competition

Enter the Shark Tank! The annual TCT meeting is the preeminent platform for concept-stage presentations of novel technologies in interventional cardiovascular medicine. Submit concept-stage novel technologies in interventional cardiovascular medicine — for a chance to present to a panel of expert judges and compete for $200,000 provided by the Jon DeHaan Foundation.

Your submission must be relevant to the monitoring, diagnosis, or treatment of coronary, endovascular, or structural heart disease and meet all three of the following criteria:

  • Addresses an unmet clinical need
  • Has preliminary patent application filed
  • Includes preclinical or early human clinical data

Guidelines: Describe clinical indication for innovative device or technology. Character limit 2,450, including spaces. Submit 15-20 PowerPoint slides covering aspects of the technology.

Submit Now


The maximum number of characters allowed is 2200 (approximately 300-350 words). This includes spaces.
Presentations of accepted Late-Breaking Trials and Science prior to TCT are strictly embargoed.